Prices delayed by at least 15 minutes | Print


iRhythm Technologies (IRTC)

Common Shares
Sell: $104.12|Buy: $113.17|Change: 0.61 (-0.57%)

Open 

$106.55


Previous close 

$106.83


Trade high 

$106.98


Volume 

488,051


Year high 

$132.92


Year low 

$70.24


Dividend yield 

-


Market capitalisation 

$3.30 bn


P/E ratio 

-


ISIN 

US4500561067


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 07/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
iRhythm Technologies- 0.57
More...

Company profile

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.